A novel cell type negatively associated with secondary autoimmunity in alemtuzumab-treated patients is revealed through single-cell longitudinal analysis of clinical trial samples

Richa Hanamsagar(Sanofi (United States)), Virginia Savova(Harvard University), Frank O. Nestlé(Guy's and St Thomas' NHS Foundation Trust), Emanuele de Rinaldis(Target (United States)), Srinivas Shankara(Sanofi (United States)), Darren P. Baker(Biogen (United States)), Robert Marcus(King's College Hospital), Mathew Chamberlain(Sanofi (United States)), K. Klinger(Sanofi (France)), Evis Havari(Sanofi (United States))
medRxiv
June 28, 2021
Cited by 0


Related Papers